Insider · CIK 0001197018

COLES N ANTHONY

Reports to the SEC for 10 companies · TARRYTOWN, NY

sec.gov

Transactions

Companies

Filings

CIK

0001197018

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+155 sh	—	—	1,714
2026-01-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,962 sh	—	—	1,962
2025-01-02	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+166 sh	—	—	1,559
2025-01-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,958 sh	—	—	1,958
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−15.6K sh	—	—	10,290
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−10.3K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−46.3K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4.81M sh	—	—	0
2024-07-01	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−25K sh	$41.18	−$1.03M	25,928
2024-07-01	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$3.50	+$87.5K	50,928
2024-07-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	2,177,417
2024-06-05	Cerevel Therapeutics Holdings, Inc.A Award	Director	AAward	+10.3K sh	—	—	25,928
2024-06-03	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−50K sh	$40.61	−$2.03M	15,638
2024-06-03	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$3.50	+$175K	65,638
2024-06-03	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	2,202,417
2024-05-10	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$3.50	+$175K	65,638
2024-05-10	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	2,252,417
2024-05-10	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−50K sh	$42.10	−$2.11M	15,638
2024-04-01	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−50K sh	$42.33	−$2.12M	15,638
2024-04-01	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$3.50	+$175K	65,638
2024-04-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	2,302,417
2024-03-04	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	2,352,417
2024-03-04	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−50K sh	$41.01	−$2.05M	15,638
2024-03-04	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$3.50	+$175K	65,638
2024-02-29	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$3.50	+$175K	65,638
2024-02-29	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	2,402,417
2024-02-29	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−50K sh	$41.16	−$2.06M	15,638
2024-02-07	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−2,506 sh	$41.54	−$104K	15,638
2024-02-06	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.4K sh	—	—	46,322
2024-02-06	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15.4K sh	—	—	18,144
2024-01-02	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+1,607 sh	—	—	1,607
2024-01-02	REGNREGENERON PHARMACEUTICALS, INC.A Award	Director	AAward	+135 sh	—	—	1,393
2024-01-02	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	2,452,417
2024-01-02	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−50K sh	$42.24	−$2.11M	2,704
2024-01-02	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$3.50	+$175K	52,704
2023-11-14	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−22.8K sh	$25.13	−$573K	2,704
2023-11-14	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+22.8K sh	$3.50	+$79.9K	25,528
2023-11-14	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−22.8K sh	—	—	2,502,417
2023-11-08	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−100 sh	$25.16	−$2,516	2,704
2023-11-08	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+100 sh	$3.50	+$350	2,804
2023-11-08	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−100 sh	—	—	2,525,241
2023-11-07	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−27.1K sh	—	—	2,525,341
2023-11-07	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+27.1K sh	$3.50	+$94.8K	29,780
2023-11-07	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−27.1K sh	$25.02	−$678K	2,704
2023-11-03	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+61.4K sh	$3.50	+$215K	64,105
2023-11-03	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−61.4K sh	$25.43	−$1.56M	2,704
2023-11-03	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−61.4K sh	—	—	2,552,417
2023-11-02	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+38.6K sh	$3.50	+$135K	41,303
2023-11-02	Cerevel Therapeutics Holdings, Inc.S Sale	Director	SSale	−38.6K sh	$25.19	−$972K	2,704
2023-11-02	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−38.6K sh	—	—	2,613,818

Recent filings

Accepted (ET)
Jan 64
COLES N ANTHONY0001197018-26-000002
SEC(opens sec.gov)
Jan 64
COLES N ANTHONY0001968202-25-000010
SEC(opens sec.gov)
Aug 54
COLES N ANTHONY0000950170-24-090789
SEC(opens sec.gov)
Jul 34
COLES N ANTHONY0000950170-24-081490
SEC(opens sec.gov)
Jun 74
COLES N ANTHONY0000950170-24-070736
SEC(opens sec.gov)
Jun 54
COLES N ANTHONY0000950170-24-069284
SEC(opens sec.gov)
May 144
COLES N ANTHONY0000950170-24-059788
SEC(opens sec.gov)
Apr 34
COLES N ANTHONY0000950170-24-041073
SEC(opens sec.gov)

Companies

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591